These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6179887)

  • 1. Antiallergic activity of tiaramide (RHC 2592-A).
    Khandwala A; Coutts S; Weinryb I
    Int Arch Allergy Appl Immunol; 1982; 69(2):159-68. PubMed ID: 6179887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
    Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A; Dally-Meade V; Jariwala N; Huang F
    Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
    Khandwala A; Coutts SM; Dally-Meade V; Jariwala N; Huang FC
    Int Arch Allergy Appl Immunol; 1983; 70(4):311-20. PubMed ID: 6186610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiallergic activity profile in vitro of RHC 2963 and related compounds.
    Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Youssefyeh RD
    Int J Immunopharmacol; 1983; 5(6):491-502. PubMed ID: 6198298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). I. Effect on release of histamine in vitro from rat peritoneal mast cells, guinea pig lung slices and human basophils.
    Khandwala A; Coutts SM; Weinryb I
    Int Arch Allergy Appl Immunol; 1983; 70(4):295-302. PubMed ID: 6186608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activity profile of RHC 2851: a new orally effective antiallergic agent.
    Khandwala A; Carlson R; Dally-Meade V; Donigi-Ruzza D
    J Immunopharmacol; 1983; 5(4):311-32. PubMed ID: 6199431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tiaramide derivative, 5-chloro-3-(4-hydroxypiperadinocarbonylmethyl)benzothiazoline-2-one (HPR-611), a potent inhibitor of anaphylactic chemical mediator release--a distinctive feature from disodium cromoglycate.
    Nabe T; Hashii H; Matsubara S; Yasui K; Yamamura H; Horiba M; Watanabe-Kohno S; Ohata K
    J Pharmacobiodyn; 1992 Dec; 15(12):673-9. PubMed ID: 1284281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds. Novel inhibitors of histamine release from rat mast cells and human basophils.
    Khandwala A; Coutts S; Dally-Meade V; Jariwala N; Musser J; Brown R; Jones H; Loev B; Weinryb I
    Biochem Pharmacol; 1983 Nov; 32(22):3325-33. PubMed ID: 6197075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. I. A lack of correlation between inhibition of cyclic nucleotide phosphodiesterases and antigen-induced release of histamine from rat mast cells.
    Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Jariwala N; Huang F; Musser J; Brown R; Loev B; Weinryb I
    Int Arch Allergy Appl Immunol; 1984; 73(1):56-64. PubMed ID: 6198287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular guanosine 3',5'-cyclic monophosphate and disodium cromoglycate share a similar spectrum of activity in the inhibition of histamine release from isolated mast cells and basophils.
    Mackay GA; Pearce FL
    Int Arch Allergy Immunol; 1996 Mar; 109(3):258-65. PubMed ID: 8620095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of traxanox sodium on IgE-mediated histamine release from passively-sensitized mast cells of the rat in vitro.
    Goto K; Hisadome M; Terasawa M
    Int Arch Allergy Appl Immunol; 1982; 68(4):332-7. PubMed ID: 6178699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of C5a-induced basophil degranulation by disodium cromoglycate.
    Golden HW; Iacuzio DA; Otterness IG
    Agents Actions; 1987 Aug; 21(3-4):371-4. PubMed ID: 2446479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological studies on oxatomide: (4) Effect on the histamine release from isolated rat peritoneal exudate cells (PEC) and lung slices].
    Ohmori K; Ishii H; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):441-9. PubMed ID: 6186585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies on the mechanism of action of a new antiallergic, Ro 21-7634.
    Welton AF; Hope WC; Crowley HJ; Salvador RA
    Agents Actions; 1981 Jul; 11(4):345-51. PubMed ID: 6169263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of ascorbic acid and disodium cromoglycate in some models of experimental anaphylaxis.
    González RG; García M; Pérez Saad H; de la Vega AR
    Allergol Immunopathol (Madr); 1979; 7(3):211-6. PubMed ID: 89807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
    Eleno N; Gajate E; Macias J; Garay RP
    Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.
    Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.